Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

Galmed Pharma (GLMD) Tops Q2 EPS by 6c

August 6, 2020 9:05 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.26), $0.06 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More